2Reede G S,Gersh B J.Modern management of acute myocardial infarction[J]. Current Problem Cardiol, 1993,18(2) : 81 - 156.
3Cohen M,Dawson M S, Kopistansky C,et al.Sex and other predictors intra - aortic ballon counterpulsation- ralated complications:prospective study of 1119 consective patients[J] .Am Heart J,2000,139(2Pt1) :282 - 287.
4张希全.辅助循环技术在心外科手术中的应用[J].山东医药,2003,43(6):57-58.
5Chen E D, Canto J G, Parsons L S. Relation between hospital introaortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock [J]. Circulation,2003,108(8) :7.
6Papaioannou T D, Terrovitis J. Heart rate effect on hemodynamics during mechanical assistance by the intro- aortic balloon pump[J ]. Int J Artif Organs, 2002,25(12): 5.
7Arceo A, Urban P. Inhospital complications of percutaneous introaortic balloon counterpulsation[J]. Angiology, 2003,54 (5): 85.
8Stone G W, Ohman E M. Contemporary utilization and outcomes of intro- aortic balloon counterpulsation in acute myocardial infarction:The benchmark registry[J] .J Am Coll Cardiol,2003,41(11) :5.
6Tokgozoglu M. Dyslipidemia, atherosclerosis, and vulnerable plaques : the effect of atorvastatin on atherosclerosis and plaque structure. Turk Kardiy- ol Dern Ars,2009,37 Supp1:6-11.
7Kultursay H. Atorvastatin in primary prevention. Turk Kardiyol Dem Ars, 2012,37 Suppl 2:17-22.
8Ongen Z, Yilmaz Y, Karadag B. Atorvastatin in secondary prevention. Turk Kardiyol Dem Ars ,2009, Suppl 2:21-23.
9Fox KM, Gandhi SK, Ohsfeldt RL, et al. Comparison of low-density lipo- protein cholesterol reduction after switching patients on other statins to ro- suvastatin or simvastatin in a real-world clinical practice setting. Am J Manaz Care,2007.13:55-57.
